GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » Capex-to-Revenue

ANGLE (ANPCF) Capex-to-Revenue : 0.34 (As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ANGLE Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

ANGLE's Capital Expenditure for the six months ended in Jun. 2023 was $-0.51 Mil. Its Revenue for the six months ended in Jun. 2023 was $1.51 Mil.

Hence, ANGLE's Capex-to-Revenue for the six months ended in Jun. 2023 was 0.34.


ANGLE Capex-to-Revenue Historical Data

The historical data trend for ANGLE's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Capex-to-Revenue Chart

ANGLE Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.96 1.99 0.66 1.77 1.81

ANGLE Semi-Annual Data
Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.58 1.02 2.36 1.45 0.34

Competitive Comparison of ANGLE's Capex-to-Revenue

For the Diagnostics & Research subindustry, ANGLE's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANGLE's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where ANGLE's Capex-to-Revenue falls into.



ANGLE Capex-to-Revenue Calculation

ANGLE's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.298) / 1.268
=1.81

ANGLE's Capex-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.511) / 1.51
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANGLE  (OTCPK:ANPCF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


ANGLE Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of ANGLE's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ANGLE (ANPCF) Business Description

Traded in Other Exchanges
Address
10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCF) Headlines

From GuruFocus

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE 04-30-2021

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire 04-12-2019